Polycystic Ovary Syndrome (PCOS) Treatment Market is Estimated To Witness High Growth
The Polycystic Ovary Syndrome (PCOS) Treatment Market is estimated to be valued at US$ 1,086.6 million in 2023 and is expected to exhibit a CAGR of 4.86% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
PCOS is a common endocrine system disorder among women of reproductive age. It occurs when the ovaries produce an excess of male hormones and results in the formation of ovarian cysts. The symptoms include irregular menstrual cycles, excess androgen levels, obesity and infertility. The treatment involves lifestyle changes, medications and procedures to manage symptoms and improve overall health.
Market key trends:
The increased awareness regarding PCOS and its treatment options through various social media platforms and patient communities is supporting the growth of this market. According to the Polycystic Ovary Syndrome Association, PCOS awareness campaigns aim to improve diagnosis rates and provide information about the lifestyle modifications and medication management. This has resulted in more women seeking medical help for PCOS related issues. Further, the development of novel drug formulations with improved efficacy and lesser side effects is also fueling the market growth. For instance, Sanofi’s Winlevi cream, the first FDA approved topical medication for acne in women with hormonal conditions like PCOS.
Market Dynamics:
The Growth Of The PCOS Treatment Market Size is driven primarily by the increasing incidence rates of PCOS globally and growing diagnosis rates. According to the American College of Obstetricians and Gynecologists, PCOS affects around 5 million women in the US. Similarly, the National Institute of Health estimates that 1 in 10 women suffer from PCOS worldwide. Rising awareness among women and physicians regarding the symptoms and risks of PCOS is positively impacting the diagnosis rates globally. Furthermore, advanced treatment options that effectively manage symptoms and risks are also augmenting the market growth over the forecast period.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it